Ifidancitinib

DB16191InvestigationalSmall molecule

Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis).

Chemical structure of Ifidancitinib
Formula / weight
C20H18FN5O3 · 395.394 g/mol (avg)
Code names
A-301 · ATI-502

Resolves to

Compound
UNIIR105E71J13CAS1236667-40-5
Structure
InChIKeyOYFMQDVLFYKOPZ-UHFFFAOYSA-NSMILESCOC1=C(F)C(C)=CC(NC2=NC=C(C)C(NC3=CC=C4OC(=O)NC4=C3)=N2)=C1
Targets
P23458JAK1P52333JAK3

What you can answer from here — as of April 23, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ifidancitinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In